Grifols revenue and EBITDA growth, improved leverage ratio, and significant liquidity highlight its resilience and potential ...

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to ...

These samples are part of Grifols’ extensive plasma repository, which contains more than 100 million specimens collected over nearly 15 years. Their medical value is in their link to real-world ...

GRIFOLS transfer bags are used for sterile preservation and administration of blood components. Blood components can be obtained, stored and preserved without contact with the environment ensuring ...

The family that owns Spanish drugmaker Grifols and private equity firm Brookfield are considering whether to take the company private in a deal that could be worth around €5.5 billion (almost $6 ...

Grifols SA engages in the production of plasma ... The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked ...

Private equity company Brookfield has reportedly moved closer to taking control of Grifols, after months of disruption at the Spanish pharma company. A report in Spanish newspaper El Confidencial ...

Grifols expects to boost revenue and free cash flow, shares soar Spanish drugmaker Grifols said on Thursday it expects its revenue, core earnings and free cash flow to grow significantly in the ...

Grifols (GRFS) hosted it 2025 Capital Markets Day on February 27 in London, where the company announced it would double revenue to EUR 14 billion over the next decade as part of an ambitious ...

Reports Q4 revenue of EUR 1.976B, up 13.6% at constant currency. Nacho Abia, Chief Executive Officer, commented, “Grifols (GRFS) delivered an all-time high performance, achieving its 2024 ...

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to take a look at where Grifols, S.A. (NASDAQ:GRFS) stands against the ...